NO980793L - Anvendelse av aminoadamantanforbindelse som immunregulatorer - Google Patents

Anvendelse av aminoadamantanforbindelse som immunregulatorer

Info

Publication number: NO980793L
Authority: NO; Norway
Prior art keywords: aminoadamantane; immune regulators; compound; aminoadamantane compound; neutrophils
Prior art date: 1995-08-25

Application number

NO980793A

Other languages

English (en)

Other versions

NO319153B1 (no

NO980793D0 (no

Inventor

Erich F Elstner

Original Assignee

Merz & Co Gmbh & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-25

Filing date

1998-02-25

Publication date

1998-02-25

1998-02-25 Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co

1998-02-25 Publication of NO980793L publication Critical patent/NO980793L/no

1998-02-25 Publication of NO980793D0 publication Critical patent/NO980793D0/no

2005-06-27 Publication of NO319153B1 publication Critical patent/NO319153B1/no

Links

-1 aminoadamantane compound Chemical class 0.000 title abstract 2
229940124644 immune regulator Drugs 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
210000000440 neutrophil Anatomy 0.000 abstract 2
208000030507 AIDS Diseases 0.000 abstract 1
DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical class C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 1
208000003669 immune deficiency disease Diseases 0.000 abstract 1
210000002381 plasma Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Mycology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Botany (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Oncology (AREA)
Diabetes (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO19980793A 1995-08-25 1998-02-25 Anvendelse av aminoadamantanforbindelse som immunregulator NO319153B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19531342A DE19531342B4 (de)	1995-08-25	1995-08-25	Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
PCT/EP1996/003678 WO1997007791A1 (en)	1995-08-25	1996-08-21	Use of aminoadamantane compounds as immunoregulators

Publications (3)

Publication Number	Publication Date
NO980793L true NO980793L (no)	1998-02-25
NO980793D0 NO980793D0 (no)	1998-02-25
NO319153B1 NO319153B1 (no)	2005-06-27

Family

ID=7770407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19980793A NO319153B1 (no)	1995-08-25	1998-02-25	Anvendelse av aminoadamantanforbindelse som immunregulator

Country Status (21)

Country	Link
US (2)	US6172116B1 (no)
EP (2)	EP1293201A3 (no)
JP (1)	JPH11512093A (no)
KR (1)	KR100392986B1 (no)
CN (1)	CN1282452C (no)
AT (1)	ATE234083T1 (no)
AU (1)	AU718219B2 (no)
CA (1)	CA2230159C (no)
CZ (1)	CZ299356B6 (no)
DE (3)	DE19531342B4 (no)
DK (1)	DK0845984T3 (no)
EE (1)	EE04261B1 (no)
ES (1)	ES2193259T3 (no)
GE (1)	GEP19991779B (no)
IL (1)	IL123394A (no)
MX (1)	MX217078B (no)
NO (1)	NO319153B1 (no)
RU (1)	RU2219916C2 (no)
UA (1)	UA57711C2 (no)
WO (1)	WO1997007791A1 (no)
ZA (1)	ZA967137B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL146143A0 (en) *	1999-04-28	2002-07-25	Univ Kingston	Compositions and methods for treating amyloidosis
RU2196575C2 (ru) *	1999-07-30	2003-01-20	Научно-исследовательский институт фармакологии РАМН	Вещество, обладающее психостимулирующим и антиастеническим действием
US6444702B1 (en)	2000-02-22	2002-09-03	Neuromolecular, Inc.	Aminoadamantane derivatives as therapeutic agents
RU2226391C2 (ru) *	2002-05-28	2004-04-10	Плотников Владимир Михайлович	Средство для повышения активности нейтрофилов
RU2246482C2 (ru) *	2002-12-25	2005-02-20	ООО "Циклан"	Способ получения гидрохлорида 1-амино-3,5-диметиладамантана
US7414076B2 (en) *	2003-06-23	2008-08-19	Neurochem (International) Limited	Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) *	2003-06-23	2007-01-11	Xianqi Kong	Methods and compositions for treating amyloid-related diseases
WO2006011823A1 (fr) *	2004-06-24	2006-02-02	Akciju Sabiedriba 'olainfarm'	Agent immunostimulateur et interférogène
BRPI0519243A2 (pt)	2004-12-22	2009-01-06	Neurochem Int Ltd	mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
DK2089417T3 (en)	2006-10-12	2015-03-23	Bhi Ltd Partnership	Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid
EP2604591A4 (en) *	2010-08-09	2015-07-22	Shionogi & Co	PROCESS FOR THE PREPARATION OF AMINOADAMANTYL CARBAMATE DERIVATIVES
WO2017223402A1 (en)	2016-06-23	2017-12-28	Corium International, Inc.	Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
CN116270551A (zh)	2016-07-27	2023-06-23	考里安有限责任公司	通过盐至中性药物原位转化的组合物、透皮贴剂及应用
WO2018022814A1 (en)	2016-07-27	2018-02-01	Corium International, Inc.	Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
EP3490544A1 (en)	2016-07-27	2019-06-05	Corium International, Inc.	Memantine transdermal delivery systems
US11173132B2 (en)	2017-12-20	2021-11-16	Corium, Inc.	Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3450761A (en) *	1967-03-30	1969-06-17	Sun Oil Co	1-aminoethyldimethyladamantane
DE4014672A1 (de) *	1990-05-08	1991-11-14	Werner E G Prof Dr Mueller	Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

1995
- 1995-08-25 DE DE19531342A patent/DE19531342B4/de not_active Expired - Fee Related
1996
- 1996-08-21 UA UA98031521A patent/UA57711C2/uk unknown
- 1996-08-21 DK DK96930065T patent/DK0845984T3/da active
- 1996-08-21 US US09/029,335 patent/US6172116B1/en not_active Expired - Fee Related
- 1996-08-21 JP JP9509816A patent/JPH11512093A/ja active Pending
- 1996-08-21 CZ CZ0052498A patent/CZ299356B6/cs not_active IP Right Cessation
- 1996-08-21 CN CNB961973471A patent/CN1282452C/zh not_active Expired - Fee Related
- 1996-08-21 RU RU98105150/14A patent/RU2219916C2/ru not_active IP Right Cessation
- 1996-08-21 EP EP02026914A patent/EP1293201A3/en not_active Withdrawn
- 1996-08-21 DE DE69626650T patent/DE69626650T2/de not_active Expired - Fee Related
- 1996-08-21 KR KR19980701329A patent/KR100392986B1/ko not_active Expired - Fee Related
- 1996-08-21 EE EE9800057A patent/EE04261B1/xx not_active IP Right Cessation
- 1996-08-21 DE DE2003199029 patent/DE10399029I1/de active Pending
- 1996-08-21 ES ES96930065T patent/ES2193259T3/es not_active Expired - Lifetime
- 1996-08-21 AU AU69263/96A patent/AU718219B2/en not_active Ceased
- 1996-08-21 WO PCT/EP1996/003678 patent/WO1997007791A1/en not_active Ceased
- 1996-08-21 EP EP96930065A patent/EP0845984B1/en not_active Expired - Lifetime
- 1996-08-21 CA CA002230159A patent/CA2230159C/en not_active Expired - Fee Related
- 1996-08-21 MX MX9801496A patent/MX217078B/es not_active IP Right Cessation
- 1996-08-21 IL IL12339496A patent/IL123394A/en not_active IP Right Cessation
- 1996-08-21 GE GEAP19964199A patent/GEP19991779B/en unknown
- 1996-08-21 AT AT96930065T patent/ATE234083T1/de not_active IP Right Cessation
- 1996-08-22 ZA ZA967137A patent/ZA967137B/xx unknown
1998
- 1998-02-25 NO NO19980793A patent/NO319153B1/no unknown
2000
- 2000-09-22 US US09/667,805 patent/US6255348B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2230159A1 (en)	1997-03-06
CA2230159C (en)	2008-02-26
EE04261B1 (et)	2004-04-15
WO1997007791A1 (en)	1997-03-06
DE10399029I1 (de)	2004-01-08
NO319153B1 (no)	2005-06-27
US6255348B1 (en)	2001-07-03
CZ52498A3 (cs)	1999-04-14
IL123394A0 (en)	1998-09-24
ZA967137B (en)	1997-03-12
KR100392986B1 (ko)	2003-11-17
US6172116B1 (en)	2001-01-09
CN1198669A (zh)	1998-11-11
DE69626650D1 (de)	2003-04-17
EP1293201A3 (en)	2003-05-21
UA57711C2 (uk)	2003-07-15
ES2193259T3 (es)	2003-11-01
DE69626650T2 (de)	2003-12-18
RU2219916C2 (ru)	2003-12-27
NO980793D0 (no)	1998-02-25
EE9800057A (et)	1998-08-17
CZ299356B6 (cs)	2008-07-02
EP0845984B1 (en)	2003-03-12
CN1282452C (zh)	2006-11-01
DE19531342A1 (de)	1997-02-27
EP1293201A2 (en)	2003-03-19
ATE234083T1 (de)	2003-03-15
MX9801496A (es)	1998-05-31
AU6926396A (en)	1997-03-19
GEP19991779B (en)	1999-10-05
DK0845984T3 (da)	2003-06-23
IL123394A (en)	2004-07-25
AU718219B2 (en)	2000-04-13
JPH11512093A (ja)	1999-10-19
MX217078B (es)	2003-10-22
KR19990044096A (ko)	1999-06-25
EP0845984A1 (en)	1998-06-10
DE19531342B4 (de)	2007-11-29

Publication	Publication Date	Title
NO980793L (no)	1998-02-25	Anvendelse av aminoadamantanforbindelse som immunregulatorer
RU94038043A (ru)	1996-11-20	Применение замещенных производных аденина для лечения множественного склероза
RU94041950A (ru)	1996-09-20	Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
DK0564924T3 (da)	1999-06-07	2-Oxoethylderivater som immunosuppressiva
AU1373499A (en)	1999-06-07	Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
DE59310085D1 (de)	2000-09-14	Indolocarbazol-imide und deren verwendung
HU910681D0 (en)	1991-09-30	Medical solution
HU913283D0 (en)	1992-01-28	Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
ATE232862T1 (de)	2003-03-15	Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
BG107537A (bg)	2003-09-30	Инхибиране на човешка tnf алфа активност
ATE50260T1 (de)	1990-02-15	Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ATE194987T1 (de)	2000-08-15	Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden
DK132188D0 (da)	1988-03-11	Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DE68926972D1 (de)	1996-09-26	Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
DE68919378D1 (de)	1994-12-22	Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
HUT46214A (en)	1988-10-28	Process for producing medical preparation suitable for treatment of peptic ulcer
NZ335057A (en)	2000-09-29	Pentaerythritol derivatives, their production and use and intermediates for their synthesis
EP0721985A4 (en)	1998-08-26	THE SUBSTANCE IT-62-B AND MEDICAL PREPARATIONS CONTAINING IT
DK653687A (da)	1988-06-13	Middel til behandling af nyresygdomme
TH24203A (th)	1997-03-19	อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
ES2037825T3 (es)	1993-07-01	Uso farmaceutico de tioeteres aromaticos.
RU94034011A (ru)	1997-04-20	Способ лечения психического расстройства
AU4246189A (en)	1990-04-12	Medicament for the treatment of diseases caused by retroviruses
TH50173A (th)	2002-03-18	การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง
UA31266A (uk)	2000-12-15	Лікувальний засіб "дінальгін"